BEHANDLUNG VON MULTIPLER SKLEROSE (MS) MIT CAMPATH-1H

Patent europeic · EP2066352 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2066352
Numer da la dumonda
EP07802348
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-09-2007
Publitgà
10-06-2009
Concedì
02-12-2015
La protecziun finescha il pli tard
10-09-2027
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 39/395 (2006.01)
C07K 16/28 (2006.01)
A61P 25/00 (2006.01)
Prioritad
US 844251 P 13.09.2006
EP 06090169 14.09.2006
Dumonda PCT
PCT/EP2007/008084 11.09.2007
Publicaziun PCT
WO2008/031626 20.03.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Alemtuzumab

C02066352/01 · Medicament · Concedì · Protecziun dals 11-09-2027 fin ils 15-12-2029

Admissiun 63025 (Swissmedic, 16-12-2014)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 08-07-2026

    Midada

    Published in Swissreg on 08.07.2026

  3. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  5. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  6. 25-01-2023

    Midada

    Published in Swissreg on 25.01.2023

  7. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  8. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

4 endataziuns pli veglias
  1. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  2. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  3. 23-06-2018

    Adressa midada

    Owner
    Alcafleu Management GmbH & Co. KG, Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, Germany, Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142, USA → Alcafleu Management GmbH & Co. KG, Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, Germany, Genzyme Corporation, 50 Binney Street, Cambridge, MA 02142, USA

    Published in Swissreg on 23.06.2018

  4. 02-12-2015

    Concedì

    Published in Swissreg on 02.12.2015

Partidas

Possessur

Alcafleu Management GmbH & Co. KG

Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, DE

Genzyme Corporation

50 Binney Street, Cambridge, MA 02142, US

Inventur

SACHSE, Andreas

10709 Berlin, DE

MARGOLIN, David Harris

Sommerville, MA 02144, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.